Ahmed Elsahy, MD
Pain Medicine · Indianapolis, INNPI 1407805690
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,011 of the $4,906 with a category attached, or 61.4%. 9 manufacturers reported payments, led by SPR Therapeutics, Inc at 34.8% of the total. Reporting peaked in 2022 at $2,070 and has fallen 98.1% since, to $39 in 2025.
Across 67 payments — averaging $73.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$2K
- Medtronic$2K
- Painteq LLC$624
- Relievant Medsystems, Inc.$546
- MML US, Inc.$162
- Avanos Medical$85
- plus $140 from 3 others
What the payments were for
- Travel & lodging$3,01161%
- Food & beverage$1,89539%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 5 | $1,710 |
| Medtronic | 18 | $1,640 |
| Painteq LLC | 35 | $624 |
| Relievant Medsystems, Inc. | 1 | $546 |
| MML US, Inc. | 1 | $162 |
| Avanos Medical | 1 | $85 |
| Abbott | 3 | $74 |
| Stryker | 2 | $48 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$1,583
- Intracept$1,092
- SYNCHROMEDII$1,085
- ReActiv8$162
- PAINTEQ$131
- INTELLIS ADAPTIVESTIM$117
How this compares
$4,906 in reported general payments places this provider in the 60th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 94 | $7,569 |
| Pregabalin | 161 | $3,610 |
| Gabapentin | 217 | $3,408 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $863 |
| Meloxicam | 194 | $592 |
| Tizanidine Hcl | 25 | $332 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $254 |
| Duloxetine Hcl | 13 | $229 |
| Oxycodone Hcl | 18 | $181 |
| Mupirocin | 21 | $174 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Indianapolis
- John SwoffordIndianapolis$127K
- Philip ShumskyIndianapolis$27K
- Michael GoldbergIndianapolis$13K
- Thelma Green MackIndianapolis$11K
- Troy PfefferkornIndianapolis$8K
- Lori KieferIndianapolis$5K
- Raheleh Rahimi DarabadIndianapolis$5K
- Ting WeiIndianapolis$5K
- John KihlkenIndianapolis$4K
- Derron WilsonCarmel$616K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.